# Heor Service Market > HEOR Service Market Research Report By Service Type (HEOR Research and Consulting, Market Access and Reimbursement, Medical Communications, Health Economics and Outcomes Research (HEOR)), By Application (Oncology, Immunology, Rare Disease, Cardiovascular Disease), By End-User (Pharmaceutical and Biotechnology Companies, Healthcare Providers, Government Agencies, Research Organizations) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.69% - **2024:** $ 28.86 Billion - **2025:** $ 30.5 Billion - **2035:** $ 53.05 Billion - **Key Players:** IQVIA (US), Optum (US), McKesson(US), Cerner (US), PAREXEL (US), Covance (US), Market Research Future Health (GB), Analysis Group (US), Evidera (US), Truist Securities (US) **Report ID:** MRFR/HC/27628-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** May 03, 2026 **URL:** https://www.marketresearchfuture.com/reports/heor-service-market-29343 --- ## Market Summary ## **HEOR Service Market Overview** As per MRFR analysis, the Heor Service Market Size was estimated at 28.86 (USD Billion) in 2024. The Heor Service Market Industry is expected to grow from 30.50 (USD Billion) in 2025 to 50.19 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 5.69% during the forecast period (2025 - 2034). ### **Key HEOR Service Market Trends Highlighted** Key market drivers for the HEOR Service Market include the increasing demand for value-based healthcare, the rising prevalence of chronic diseases, and the growing adoption of personalized medicine. Opportunities in the HEOR Service Market lie in the expansion of digital health technologies, partnerships with pharmaceutical companies, and the development of innovative HEOR solutions. Recent trends in the HEOR Service Market include the integration of artificial intelligence and machine learning, the use of real-world data, and the focus on patient-centered outcomes. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **HEOR Service Market Drivers** Rising Demand for Value-Based Healthcare The increasing focus on value-based healthcare is a major driver of growth in the Global HEOR Service Market Industry. As healthcare providers and payers seek to optimize outcomes and reduce costs, they are increasingly turning to HEOR services to demonstrate the value of their products and services. HEOR services can help companies develop and implement value-based pricing strategies, conduct cost-effectiveness analyses, and measure the impact of their products on patient outcomes. By providing evidence of the value of their products, companies can increase their chances of reimbursement and market share. The rising demand for value-based healthcare is being driven by a number of factors, including the increasing prevalence of chronic diseases, the rising cost of healthcare, and the growing number of value-based payment models. As a result, the demand for HEOR services is expected to continue to grow in the coming years. Here are some specific examples of how HEOR services are being used to support value-based healthcare: Developing and implementing value-based pricing strategies: HEOR services can help companies develop value-based pricing strategies that are aligned with the value that their products provide to patients. This can involve conducting market research to understand the value that patients place on different attributes of a product, and developing pricing models that reflect this value. Conducting cost-effectiveness analyses: HEOR services can help companies conduct cost-effectiveness analyses to assess the value of their products compared to other treatment options. This can involve estimating the costs and benefits of a product over its lifetime and comparing these costs and benefits to those of other products. Measuring the impact of products on patient outcomes: HEOR services can help companies to measure the impact of their products on patient outcomes. This can involve conducting clinical trials to assess the efficacy and safety of a product and collecting data on patient outcomes in real-world settings. Technological Advancements The Global HEOR Service Market Industry is also being driven by technological advancements. The development of new technologies, such as big data analytics and artificial intelligence (AI), is making it possible to collect and analyze large amounts of data on patient outcomes. This data can be used to develop more accurate and personalized HEOR analyses. Increasing Regulatory Requirements The increasing regulatory requirements for HEOR services is another factor driving growth in the Global HEOR Service Market Industry. In many countries, healthcare providers and payers are required to demonstrate the value of their products and services before they can be reimbursed. This has led to an increased demand for HEOR services as companies seek to comply with these requirements. ## **HEOR Service Market Segment Insights** ### **HEOR Service Market Service Type Insights** The Global HEOR Service Market is segmented by Service Type into HEOR Research and Consulting, Market Access and Reimbursement, Medical Communications, and Health Economics and Outcomes Research (HEOR). Among these segments, HEOR Research and Consulting held the largest market share in 2023 and is projected to maintain its dominance throughout the forecast period. The growth of this segment can be attributed to the increasing demand for HEOR studies to support drug development and regulatory submissions. Market Access and Reimbursement is another significant segment, driven by the rising need for assistance in navigating complex reimbursement landscapes. Medical Communications is also gaining traction as companies seek to effectively communicate the value of their products to healthcare professionals and patients. Health Economics and Outcomes Research (HEOR) is expected to witness steady growth due to its importance in assessing the cost-effectiveness and value of healthcare interventions. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **HEOR Service Market Application Insights** Application Segment Insight and Overview The application segment of the Global HEOR Service Market offers diverse opportunities and challenges. Oncology, immunology, rare diseases, and cardiovascular disease represent key therapeutic areas driving market growth. Oncology emerged as the largest application segment, accounting for a significant share of the Global HEOR Service Market revenue in 2023. The increasing prevalence of cancer and the development of novel oncology therapies fuel this segment's growth. Immunology is another rapidly expanding application segment driven by the rising prevalence of immune-mediated diseases and the advancements in immunotherapy. The segment is anticipated to witness substantial growth over the forecast period. Rare Disease presents a niche but growing market segment. The increasing recognition of rare diseases and the development of targeted therapies for these conditions drive segment growth. Cardiovascular Disease remains a major application area, with the increasing incidence of heart conditions and the need for effective patient management. The segment is expected to contribute significantly to the Global HEOR Service Market growth in the coming years. Overall, the application segment of the Global HEOR Service Market exhibits a promising outlook, with Oncology, [Immunology](../../../reports/immunology-market-30261) , Rare Disease, and cardiovascular disease serving as key growth drivers. ### **HEOR Service Market End-User Insights** The Global HEOR Service Market segmentation by End-User includes Pharmaceutical and Biotechnology Companies, Healthcare Providers, Government Agencies, and Research Organizations. Pharmaceutical and Biotechnology companies accounted for the largest share of the market in 2023, owing to the increasing need for HEOR studies to support drug development and commercialization. Healthcare providers are expected to witness significant growth, driven by the rising adoption of HEOR to improve patient outcomes and reduce healthcare costs. Government agencies are also expected to contribute to the market growth due to the growing emphasis on healthcare cost-effectiveness and value-based pricing. Research organizations are anticipated to play a crucial role in conducting HEOR studies and providing insights to support decision-making in the healthcare industry. ### **HEOR Service Market Regional Insights** The Global HEOR Service Market is expected to witness significant growth in the coming years. Regionally, North America held the largest market share in 2023, with a valuation of 10.5 billion USD. Europe is expected to follow with a market size of 7.2 billion USD, while APAC is projected to grow at the highest CAGR of 7.1% during the forecast period 2025-2034 South America and MEA contributed to the overall market growth, with market sizes of 3.2 billion USD and 2.9 billion USD, respectively, in 2023. The increasing adoption of HEOR services by pharmaceutical and biotechnology companies, along with growing government support for healthcare research and development, is driving the market growth. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **HEOR Service Market Key Players and Competitive Insights** Major players in the HEOR Service Market industry are constantly striving to stay ahead of the competition by investing in research and development, expanding their service offerings, and forming strategic partnerships. Leading HEOR Service Market players are focusing on providing innovative solutions that cater to the evolving needs of clients in the pharmaceutical and biotechnology industries. The HEOR Service Market development is driven by the increasing demand for evidence-based decision-making in healthcare, the growing complexity of clinical trials, and the need for efficient and effective communication of health outcomes. IQVIA is a leading provider of HEOR Service Market services globally. The company offers a comprehensive suite of solutions that cover the entire drug development lifecycle, from early-stage research to post-marketing surveillance. IQVIA has a strong track record of success in delivering high-quality HEOR Service Market services to clients in the pharmaceutical and biotechnology industries. The company's team of experts has deep knowledge and experience in the field of HEOR Service Market and they are committed to providing innovative solutions that meet the evolving needs of clients.  Another major player in the HEOR Service Market industry is Evidera. The company offers a range of HEOR Service Market services, including clinical trial design and analysis, health economics and outcomes research, and market access and reimbursement support. Evidera has a strong reputation for providing high-quality HEOR Service Market services to clients in the pharmaceutical and biotechnology industries. The company's team of experts has deep knowledge and experience in the field of the HEOR Service Market, and they are committed to providing innovative solutions that meet the evolving needs of clients. **Key Companies in the HEOR Service Market Include** ## **HEOR Service Market Industry Developments** The growth is attributed to factors such as the increasing adoption of value-based healthcare, the rising prevalence of chronic diseases, and the growing demand for personalized medicine. Key industry participants are focusing on strategic collaborations, acquisitions, and partnerships to expand their service offerings and gain a competitive edge in the market. Recent developments include the acquisition of Health Economics and Outcomes Research firm Precision Health Economics by Evidera in 2023 and the partnership between IQVIA and Aetion in 2022 to enhance real-world evidence-generation capabilities. The market is expected to witness continued growth in the coming years, driven by advancements in technology, increasing government support for HEOR, and the growing adoption of digital health solutions. ## **HEOR Service Market Segmentation Insights** ### **HEOR Service Market Service Type Outlook** ### **HEOR Service Market Application Outlook** ### **HEOR Service Market End-User Outlook** ### **HEOR Service Market Regional Outlook** ## Market Drivers ### Focus on Value-Based Care The HEOR Service Market is increasingly aligning with the principles of value-based care, which emphasizes patient outcomes relative to costs. This paradigm shift is driven by healthcare payers and providers seeking to optimize resource allocation while ensuring high-quality care. According to recent data, approximately 70% of healthcare organizations are transitioning towards value-based care models. This trend necessitates robust health economic evaluations to demonstrate the cost-effectiveness of treatments and interventions. Consequently, HEOR services are becoming indispensable for organizations aiming to navigate this complex landscape. By providing evidence that supports the economic value of healthcare interventions, HEOR services play a critical role in influencing reimbursement decisions and policy formulations, thereby shaping the future of healthcare delivery. ### Regulatory Changes and Compliance The HEOR Service Market is significantly influenced by evolving regulatory frameworks that demand rigorous health economic evaluations. Regulatory bodies are increasingly requiring evidence of cost-effectiveness and budget impact analyses for new therapies before granting market access. This trend is particularly evident in regions where healthcare costs are under scrutiny, prompting stakeholders to invest in HEOR services to ensure compliance. For example, recent regulations in various jurisdictions mandate that pharmaceutical companies submit comprehensive economic evaluations alongside clinical data. This shift underscores the importance of HEOR services in navigating the complex regulatory landscape, as they provide the necessary evidence to support market access and reimbursement negotiations. Consequently, organizations that leverage HEOR services are better positioned to meet regulatory requirements and enhance their market presence. ### Integration of Advanced Technologies The HEOR Service Market is experiencing a notable shift due to the integration of advanced technologies such as artificial intelligence and machine learning. These technologies facilitate the analysis of vast datasets, enabling more accurate health economic evaluations. For instance, AI algorithms can predict patient outcomes and treatment costs, which enhances decision-making processes for healthcare providers. The market for AI in healthcare is projected to reach approximately 36 billion USD by 2025, indicating a robust growth trajectory. This technological advancement not only streamlines operations but also improves the quality of evidence generated, thereby influencing policy decisions and reimbursement strategies. As a result, stakeholders in the HEOR Service Market are increasingly adopting these technologies to remain competitive and meet the evolving demands of healthcare systems. ### Rising Demand for Real-World Evidence The HEOR Service Market is witnessing a surge in demand for real-world evidence (RWE) as stakeholders seek to understand the effectiveness of interventions in everyday clinical settings. RWE provides insights that are often absent from traditional clinical trials, thereby offering a more comprehensive view of treatment outcomes. Recent studies indicate that over 60% of pharmaceutical companies are utilizing RWE to inform their product development and market access strategies. This growing reliance on RWE is reshaping the landscape of health economics and outcomes research, as it allows for more nuanced evaluations of healthcare interventions. As a result, HEOR services that specialize in generating and analyzing RWE are becoming increasingly vital for organizations aiming to demonstrate the value of their products in real-world scenarios. ### Increased Focus on Patient-Centric Approaches The HEOR Service Market is increasingly prioritizing patient-centric approaches, reflecting a broader trend towards personalized medicine. This shift emphasizes the importance of understanding patient preferences, experiences, and outcomes in health economic evaluations. Recent surveys indicate that nearly 80% of healthcare stakeholders believe that incorporating patient-reported outcomes is essential for effective decision-making. As a result, HEOR services are adapting to include methodologies that capture these patient perspectives, thereby enhancing the relevance and applicability of their findings. This focus on patient-centricity not only improves the quality of health economic assessments but also aligns with the growing demand for transparency and accountability in healthcare. By integrating patient insights into their evaluations, HEOR services are better equipped to inform policy decisions and improve healthcare delivery. ## Future Outlook The HEOR Service Market is projected to grow at a 5.69% CAGR from 2025 to 2035, driven by increasing demand for value-based healthcare and advanced analytics. **New opportunities:** - Development of AI-driven health economic models Expansion of real-world evidence generation services Integration of [digital health](https://www.marketresearchfuture.com/reports/digital-healthcare-market-7636) solutions in HEOR strategies By 2035, the HEOR Service Market is expected to be robust, reflecting substantial growth and innovation. ## Segment Insights ### By Service Type: HEOR Research and Consulting (Largest) vs. Market Access and Reimbursement (Fastest-Growing) The HEOR Service Market showcases diverse offerings, with HEOR Research and Consulting holding the largest share due to its critical role in guiding healthcare decisions. This segment emphasizes robust data analytics and expert consultation, ensuring pharmaceutical companies and healthcare providers align their strategies with evolving market dynamics. In contrast, Market Access and Reimbursement is gaining traction, driven by increasing demand for effective strategies that ensure product accessibility and reimbursement, highlighting its strength as a key player for future growth. HEOR Research and Consulting (Dominant) vs. Medical Communications (Emerging) HEOR Research and Consulting is recognized as the dominant force within the HEOR Service Market, providing essential analysis and strategic advice tailored to industry needs. This segment is fundamentally critical, supporting pharmaceutical and healthcare firms in navigating complex regulatory requirements and optimizing product placement in the market. On the other hand, Medical Communications represents an emerging segment, focusing on the dissemination of scientific data, evidence generation, and stakeholder engagement. This area is expanding rapidly, fueled by the increasing need for effective communication strategies in a landscape defined by heightened competition and an informed patient population seeking clarity on health-related decisions. ### By Application: Oncology (Largest) vs. Immunology (Fastest-Growing) In the HEOR Service Market, Oncology holds the largest market share, driven by the increasing prevalence of cancer and the demand for robust healthcare outcomes. This segment's dominance is supported by a growing focus on personalized medicine and targeted therapies, making it a critical area for health economic evaluations. In contrast, [Immunology](https://www.marketresearchfuture.com/reports/immunology-market-30261)is emerging as the fastest-growing segment, fueled by advancements in biopharmaceuticals and a surge in autoimmune disorders. This growth reflects the heightened awareness and recognition of immunological diseases, propelling research and service demands forward. Oncology: Dominant vs. Immunology: Emerging Oncology is the dominant segment in the HEOR Service Market due to its established infrastructure and extensive research initiatives dedicated to cancer treatment and management. The segment benefits from continuous innovation in therapies and increasing healthcare focus on cancer care outcomes. Conversely, Immunology, while currently under the spotlight as an emerging segment, is rapidly gaining traction. The segment is characterized by novel biologics and monoclonal antibodies that are transforming treatment paradigms for autoimmune conditions. Its growth is supported by pivotal clinical trials and the evolving understanding of immune-mediated diseases, positioning it as a key focus area for HEOR services. ### By End-User: Pharmaceutical and Biotechnology Companies (Largest) vs. Healthcare Providers (Fastest-Growing) In the HEOR Service Market, the distribution of market share among end-users reveals a significant concentration of demand from Pharmaceutical and Biotechnology Companies. This segment remains the largest end-user, driven by the need for comprehensive economic assessments to support drug development and reimbursement strategies. Healthcare Providers follow as a crucial segment, contributing to the overall demand for HEOR services as they seek to streamline costs while ensuring patient access to effective treatments. Pharmaceutical and Biotechnology Companies (Dominant) vs. Healthcare Providers (Emerging) Pharmaceutical and Biotechnology Companies dominate the HEOR Service Market, leading in the utilization of health economics and outcomes research to guide decision-making for drug development and market access. Their reliance on HEOR services is rooted in the necessity to demonstrate value and efficacy to payers and regulatory bodies. Meanwhile, Healthcare Providers, as emerging players, are increasingly recognizing the importance of HEOR in optimizing their budgets and enhancing care delivery. They face growing pressure to justify clinical decisions with data-driven evidence, thus turning to HEOR services to align clinical outcomes with cost-effectiveness, facilitating their evolution into more economically aware entities. ## Regional Market Share Analysis The Global HEOR Service Market is expected to witness significant growth in the coming years. Regionally, North America held the largest market share in 2023, with a valuation of 10.5 billion USD. Europe is expected to follow with a market size of 7.2 billion USD, while APAC is projected to grow at the highest CAGR of 7.1% during the forecast period 2025-2034 South America and MEA contributed to the overall market growth, with market sizes of 3.2 billion USD and 2.9 billion USD, respectively, in 2023. The increasing adoption of HEOR services by pharmaceutical and biotechnology companies, along with growing government support for healthcare research and development, is driving the market growth. ## Competitive Benchmarking The HEOR Service Market is currently characterized by a dynamic competitive landscape, driven by the increasing demand for evidence-based healthcare solutions and the need for cost-effective treatment options. Key players such as IQVIA (US), Optum (US), and PAREXEL (US) are strategically positioned to leverage their extensive data analytics capabilities and healthcare expertise. These companies are focusing on innovation and digital transformation to enhance their service offerings, thereby shaping a competitive environment that emphasizes data-driven decision-making and patient-centric approaches. In terms of business tactics, companies are increasingly localizing their services to better cater to regional healthcare needs, optimizing their supply chains to improve efficiency. The market appears moderately fragmented, with several players vying for market share, yet the collective influence of major companies like McKesson (US) and Covance (US) is significant. Their operational strategies often involve partnerships and collaborations that enhance their service capabilities and market reach. In August 2025, IQVIA (US) announced a strategic partnership with a leading pharmaceutical company to develop advanced analytics tools aimed at improving patient outcomes. This collaboration is likely to enhance IQVIA's position in the market by integrating real-world evidence into clinical decision-making, thereby reinforcing its commitment to innovation in HEOR services. The implications of this partnership may extend beyond immediate financial gains, potentially setting new standards for evidence generation in the industry. In September 2025, Optum (US) launched a new digital platform designed to streamline the integration of health economics and outcomes research into clinical workflows. This initiative reflects Optum's focus on digital transformation and its aim to provide healthcare providers with actionable insights. By enhancing the accessibility of HEOR data, Optum is likely to strengthen its competitive edge, positioning itself as a leader in the integration of technology and healthcare analytics. In July 2025, PAREXEL (US) expanded its global footprint by acquiring a regional HEOR consultancy in Europe. This acquisition is indicative of PAREXEL's strategy to enhance its service offerings and expand its market presence. By integrating local expertise with its global capabilities, PAREXEL may improve its competitive positioning and better serve its clients in diverse markets. As of October 2025, the HEOR Service Market is witnessing trends such as increased digitalization, the integration of artificial intelligence, and a growing emphasis on sustainability. Strategic alliances among key players are shaping the competitive landscape, fostering innovation and collaboration. Looking ahead, it appears that competitive differentiation will increasingly hinge on technological advancements and the reliability of supply chains, rather than solely on price. This shift suggests a potential evolution in how companies approach competition, with a greater focus on delivering innovative solutions that meet the complex needs of the healthcare ecosystem. ## Recent News & Developments The growth is attributed to factors such as the increasing adoption of value-based healthcare, the rising prevalence of chronic diseases, and the growing demand for personalized medicine. Key industry participants are focusing on strategic collaborations, acquisitions, and partnerships to expand their service offerings and gain a competitive edge in the market. Recent developments include the acquisition of Health Economics and Outcomes Research firm Precision Health Economics by Evidera in 2023 and the partnership between IQVIA and Aetion in 2022 to enhance real-world evidence-generation capabilities. The market is expected to witness continued growth in the coming years, driven by advancements in technology, increasing government support for HEOR, and the growing adoption of digital health solutions. ## Report Scope | MARKET SIZE 2024 | 28.86(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 30.5(USD Billion) | | MARKET SIZE 2035 | 53.05(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.69% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | IQVIA (US), Optum (US), McKesson (US), Cerner (US), PAREXEL (US), Covance (US), Market Research Future Health (GB), Analysis Group (US), Evidera (US), Truist Securities (US) | | Segments Covered | Service Type, Application, End-User, Regional | | Key Market Opportunities | Integration of advanced analytics and artificial intelligence in HEOR Service Market enhances decision-making and value demonstration. | | Key Market Dynamics | Rising demand for Health Economics and Outcomes Research services driven by regulatory changes and technological advancements. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the projected market valuation of the HEOR Service Market by 2035?** A: The HEOR Service Market is projected to reach a valuation of 53.05 USD Billion by 2035. **Q: What was the market valuation of the HEOR Service Market in 2024?** A: In 2024, the HEOR Service Market was valued at 28.86 USD Billion. **Q: What is the expected CAGR for the HEOR Service Market from 2025 to 2035?** A: The expected CAGR for the HEOR Service Market during the forecast period 2025 - 2035 is 5.69%. **Q: Which companies are considered key players in the HEOR Service Market?** A: Key players in the HEOR Service Market include IQVIA, Optum, McKesson, Cerner, and PAREXEL. **Q: What are the main service types within the HEOR Service Market?** A: Main service types include HEOR Research and Consulting, Market Access and Reimbursement, and Medical Communications. **Q: How much is the HEOR Research and Consulting segment projected to grow by 2035?** A: The HEOR Research and Consulting segment is projected to grow from 8.0 USD Billion in 2024 to 15.0 USD Billion by 2035. **Q: What is the projected growth for the Market Access and Reimbursement segment by 2035?** A: The Market Access and Reimbursement segment is expected to increase from 10.0 USD Billion in 2024 to 18.0 USD Billion by 2035. **Q: Which application areas are driving growth in the HEOR Service Market?** A: Application areas driving growth include Oncology, Immunology, Rare Disease, and Cardiovascular Disease. **Q: What is the expected market size for the Cardiovascular Disease application by 2035?** A: The market size for the Cardiovascular Disease application is projected to grow from 7.86 USD Billion in 2024 to 16.05 USD Billion by 2035. **Q: Who are the primary end-users of HEOR services?** A: Primary end-users of HEOR services include Pharmaceutical and Biotechnology Companies, Healthcare Providers, and Government Agencies. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/heor-service-market-29343*